Methodology and Evaluation for Machine Learning in Drug Molecule Design

Open Access

Issue		BIO Web Conf. Volume 237, 2026 2026 8^th International Conference on Biotechnology and Biomedicine (ICBB 2026)


Article Number		02006
Number of page(s)		7
Section		Pharmacology, Natural Products and Drug Delivery
DOI		https://doi.org/10.1051/bioconf/202623702006
Published online		10 June 2026

Torjesen, I. (2015, May 12). Drug development: the journey of a medicine from lab to shelf. the Pharmaceutical Journal. https://pharmaceutical-journal.com/article/feature/drug-development-the-journey-of-a-medicine-from-lab-to-shelf [Google Scholar]
Rousseaux, C. G., Bracken, W. M., & Guionaud, S. (2023). Chapter 1 - Overview of Drug Development. In W. M. Haschek, C. G. Rousseaux, M. A. Wallig, B. Bolon, B. Bolon, K. M. Heinz-Taheny, D. G. Rudmann, & B. W. Mahler (Eds.), Haschek and Rousseaux’ s Handbook of Toxicologic Pathology (Fourth Edition) (pp. 3–48). Academic Press. https://doi.org/10.1016/B978-0-12-821047-5.00016-6 [Google Scholar]
Fermini, B., & Bell, D. C. (2022). On the perspective of an aging population and its potential impact on drug attrition and pre-clinical cardiovascular safety assessment. J Pharmacol Toxicol Methods, 117, 107184. https://doi.org/10.1016/j.vascn.2022.107184 [Google Scholar]
Drenth-van Maanen, A. C., Wilting, I., & Jansen, P. A. F. (2020). Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol, 86(10), 1921–1930. https://doi.org/10.1111/bcp.14094 [Google Scholar]
Temple, J. (2020, February 26). 10 Breakthrough Technologies 2020. MIT Technology Review. https://www.technologyreview.com/10-breakthrough-technologies/2020/ [Google Scholar]
Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022). Deep learning tools for advancing drug discovery and development. 3 Biotech, 12(5), 110. https://doi.org/10.1007/s13205-022-03165-8 [CrossRef] [PubMed] [Google Scholar]
Xu, Z., Ren, F., Wang, P. et al. (2025). A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med 31, 2602–2610. https://doi.org/10.1038/s41591-025-03743-2 [Google Scholar]
Pang, C., Qiao, J. B., Zeng, X. X., Zou, Q., & Wei, L. Y. (2023). Deep Generative Models in De Novo Drug Molecule Generation [Review]. Journal of Chemical Information and Modeling, 64(7), 2174–2194. https://doi.org/10.1021/acs.jcim.3c01496 [Google Scholar]
Weininger, D. (1988). SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. Journal of Chemical Information and Computer Sciences, 28(1), 31–36. https://doi.org/10.1021/ci00057a005 [Google Scholar]
Wigh, D. S., Goodman, J. M., & Lapkin, A. A. (2022). A review of molecular representation in the age of machine learning. WIREs Computational Molecular Science, 12(5). https://doi.org/10.1002/wcms.1603 [Google Scholar]
Bjerrum, E. J. (2017). SMILES Enumeration as Data Augmentation for Neural Network Modeling of Molecules. arXiv preprint arXiv:1703.07076. https://doi.org/10.48550/arXiv.1703.07076 [Google Scholar]
Leon, M., Perezhohin, Y., Peres, F., Popovic, A., & Castelli, M. (2024). Comparing SMILES and SELFIES tokenization for enhanced chemical language modeling. Sci Rep, 14(1), 25016. https://doi.org/10.1038/s41598-024-76440-8 [Google Scholar]
Guo, Z., Guo, K., Nan, B., Tian, Y., Iyer, R. G., Ma, Y., Wiest, O., Zhang, X., Wang, W., Zhang, C., & Chawla, N. V. (2023). Graph-based Molecular Representation Learning. arXiv preprint arXiv:2207.04869. https://doi.org/10.48550/arXiv.2207.04869 [Google Scholar]
David, L., Thakkar, A., Mercado, R., & Engkvist, O. (2020). Molecular representations in AI-driven drug discovery: a review and practical guide. J Cheminform, 12(1), 56. https://doi.org/10.1186/s13321-020-00460-5 [Google Scholar]
Zeng, X., Xiang, H., Yu, L., Wang, J., Li, K., Nussinov, R., & Cheng, F. (2022). Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework. Nature Machine Intelligence, 4(11), 1004–1016. https://doi.org/10.1038/s42256-022-00557-6 [Google Scholar]
Chen, X., & Qian, Q. (2023). subGE: Enhancing the subgraph representation of molecular compounds structure–activity relationship discovery. Engineering Applications of Artificial Intelligence, 119. https://doi.org/10.1016/j.engappai.2022.105727 [Google Scholar]
Wang, S., Zhang, R., Li, X., Cai, F., Ma, X., Tang, Y., Xu, C., Wang, L., Ren, P., Liu, L., Wu, S., Qian, Q., & Bai, F. (2025). Recent advances in molecular representation methods and their applications in scaffold hopping. npj Drug Discovery, 2(1). https://doi.org/10.1038/s44386-025-00017-2 [Google Scholar]
Tong, X., Liu, X., Tan, X., Li, X., Jiang, J., Xiong, Z., Xu, T., Jiang, H., Qiao, N., & Zheng, M. (2021). Generative Models for De Novo Drug Design. J Med Chem, 64(19), 14011–14027. https://doi.org/10.1021/acs.jmedchem.1c00927 [Google Scholar]
Blanchard, A. E., Stanley, C., & Bhowmik, D. (2021). Using GANs with adaptive training data to search for new molecules. J Cheminform, 13(1), 14. https://doi.org/10.1186/s13321-021-00494-3 [Google Scholar]
Cao, N. D., & Kip, T. (2022). MolGAN: An implicit generative model for small molecular graphs. arXiv preprint arXiv:1805.11973. https://doi.org/10.48550/arXiv.1805.11973 [Google Scholar]
Gupta, A., Muller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018). Generative Recurrent Networks for De Novo Drug Design. Mol Inform, 37(1-2). https://doi.org/10.1002/minf.201700111 [Google Scholar]
Olivecrona, M., Blaschke, T., Engkvist, O., & Chen, H. (2017). Molecular de-novo design through deep reinforcement learning. J Cheminform, 9(1), 48. https://doi.org/10.1186/s13321-017-0235-x [Google Scholar]
Gomez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernandez-Lobato, J. M., Sanchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018). Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. ACS Cent Sci, 4(2), 268–276. https://doi.org/10.1021/acscentsci.7b00572 [Google Scholar]
Mswahili, M. E., & Jeong, Y. S. (2024). Transformer- based models for chemical SMILES representation: A comprehensive literature review. Heliyon, 10(20), e39038. https://doi.org/10.1016/j.heliyon.2024.e39038 [Google Scholar]
Irwin, R., Dimitriadis, S., He, J., & Bjerrum, E. J. (2022). Chemformer: a pre-trained transformer for computational chemistry. Machine Learning: Science and Technology, 3(1). https://doi.org/10.1088/2632-2153/ac3ffb [Google Scholar]
Alakhdar, A., Poczos, B., & Washburn, N. (2024). Diffusion Models in De Novo Drug Design. J Chem Inf Model, 64(19), 7238–7256. https://doi.org/10.1021/acs.jcim.4c01107 [Google Scholar]
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25.1. Advanced Drug Delivery Reviews, 46(1), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0 [CrossRef] [PubMed] [Google Scholar]
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012). Quantifying the chemical beauty of drugs. Nat Chem, 4(2), 90–98. https://doi.org/10.1038/nchem.1243 [Google Scholar]
Cieplinski, T., Danel, T., Podlewska, S., & Jastrzebski, S. (2023). Generative Models Should at Least Be Able to Design Molecules That Dock Well: A New Benchmark. J Chem Inf Model, 63(11), 3238–3247. https://doi.org/10.1021/acs.jcim.2c01355 [Google Scholar]
Zhou, G., Rusnac, D. V., Park, H., Canzani, D., Nguyen, H. M., Stewart, L., Bush, M. F., Nguyen, P. T., Wulff, H., Yarov-Yarovoy, V., Zheng, N., & DiMaio, F. (2024). An artificial intelligence accelerated virtual screening platform for drug discovery. Nat Commun, 15(1), 7761. https://doi.org/10.1038/s41467-024-52061-7 [Google Scholar]
Ertl, P., & Schuffenhauer, A. (2009). Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform, 1(1), 8. https://doi.org/10.1186/1758-2946-1-8 [Google Scholar]
Skoraczynski, G., Kitlas, M., Miasojedow, B., & Gambin, A. (2023). Critical assessment of synthetic accessibility scores in computer-assisted synthesis planning. J Cheminform, 15(1), 6. https://doi.org/10.1186/s13321-023-00678-z [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.